2,2-bis(4-glycidyloxyphenyl)propane has been researched along with quinolinic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalonia, H; Kumar, A; Kumar, P | 1 |
1 other study(ies) available for 2,2-bis(4-glycidyloxyphenyl)propane and quinolinic acid
| Article | Year |
|---|---|
Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Body Weight; Corpus Striatum; Disease Models, Animal; Electron Transport Chain Complex Proteins; Epoxy Compounds; Humans; Huntington Disease; Male; Motor Skills; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Pioglitazone; PPAR gamma; Quinolinic Acid; Rats; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2010 |